Defiance Autism Impact ET... (ASD)
NasdaqGM: ASD
· リアルタイム株価 · USD
28.17
+0.00 (0.00%)
終値時点： Aug 26, 2026, 9:43 AM
Defiance Autism Impact ETF（ASD）ETFの価格・保有銘柄・分析
0.00% (1D)
| 買気配 | 19.62 |
| 時価総額 | n/a |
| 純資産総額 | 1.33M |
| 基準価額 | 28.04 |
| ベータ | n/a |
| EPS（過去12か月） | n/a |
| PER（過去12か月） | 21.83 |
| 発行済口数 | n/a |
| 設定日 | Jun 1, 2026 |
| 売気配 | 34.96 |
| 出来高 | 9 |
| 平均出来高（20日） | 585 |
| 始値 | 27.71 |
| 前日終値 | 28.17 |
| 日中値幅 | 28.17 - 28.17 |
| 52週の値幅 | 24.59 - 28.52 |
| 組入銘柄 | n/a |
| 経費率 | 0.79% |
ASDについて
Under normal circumstances, the fund invests at least 80% of its net assets (plus borrowings for investment purposes) in Autism Impact Companies. The index is designed to measure the performance of publicly traded global companies in developed markets that provide products, services and/or research supporting the autism ecosystem comprised of individuals on the autism spectrum and within the broader neurodivergent community (“Autism Impact Companies”). It is non-diversified.
主なセクター
| セクター | 構成比 % |
|---|---|
| Healthcare | 87.46% |
| Consumer Defensive | 4.39% |
| Consumer Cyclical | 2.84% |
| Communication Services | 2.78% |
| Industrials | 2.54% |
上位10銘柄 純資産の31.15%
| 名称 | シンボル | 構成比 |
|---|---|---|
| Definium Therapeutic... | DFTX | 4.48% |
| Neuren Pharmaceutica... | NEU.AX | 3.37% |
| Otsuka Holdings Co L... | 4578.T | 3.14% |
| Lifestance Health Gr... | LFST | 3.02% |
| Acadia Pharmaceutica... | ACAD | 3.00% |
| Acadia Healthcare Co... | ACHC | 2.95% |
| Bristol-myers Squibb... | BMY | 2.84% |
| Bright Horizons Fami... | BFAM | 2.83% |
| Pearson PLC | PSON.L | 2.77% |
| Revvity Inc | RVTY | 2.75% |
